European Hematology Association (EHA)’s Post

#PrecisionMedicine is setting a new standard by offering tailored solutions for individuals based on their unique physiology and genetic makeup. While their potential to change #patientlives is undeniable, precision medicine trials also face a number of unique challenges, including complex sample collection requirements and the need for seamless coordination between trial stakeholders. Read more below to learn whether it's possible to work around these challenges and what your first step should be. #ClinicalInnovation #SampleManagement #ClinicalTechnology #BiospecimenManagement

Want to read up on VarSeq in action? Our latest blog post, highlights the remarkable advances in precision medicine driven by recent publications featuring VarSeq! Discover how our innovative solutions are transforming genetic research and clinical diagnostics, paving the way for personalized healthcare. Read the full blog to explore how VarSeq is making a significant impact in the field: https://bit.ly/3LIcbPg #PrecisionMedicine #GeneticResearch #VarSeq #GoldenHelix #Innovation #Healthcare #ClinicalDiagnostics #PersonalizedMedicine

The rise of precision medicine has improved healthcare. The concept of the one-size-fits-all clinical trial has been improved by the introduction of biomarker-guided approaches (e.g., basket, umbrella, and platform trials) that tailor treatments based on genetic and molecular characteristics. This shift hopefully will continue to improve the efficiency and effectiveness of clinical trials. #PrecisionMedicine #ClinicalTrials #ClinicalResearch #PersonalizedHealthcare #DrugDevelopment #InnovationInMedicine #MedicalCommunications https://lnkd.in/eWG_bEfk

The whole is greater than the sum of its parts: Long-read sequencing for solving clinical problems in haematology Congrats CIBERER-ISCIII nodule for this interesting publication abotu how long reads advantages for identifying structural variations (SVs) in haematological neoplasms https://lnkd.in/dyaueycC

Sherry Dadgar, Ph.D., FACMG, envisioned a world where physicians could provide care based on their patients' genetics and genomic characteristics, and she set out to help pave the way to #PersonalizedMedicine. In 2020, Dr. Dadgar launched Personalized Medicine Care Diagnostics (PMCDx), a laboratory that specializes in low-cost, advanced clinical genomic diagnostic testing. Through PMCDx, she aims to improve #PrecisionMedicine and empower physicians to provide truly personalized care. Read her story ➡️ https://lnkd.in/eRVfpT4E #PMCDx #pharmacogenomics #GeneticTesting

Precision Diagnostics: The Future of Personalized Medicine - Explore the world of precision diagnostics, where cutting-edge technologies tailor treatments by unlocking each individual's genetic and molecular profile. #Diagnostics #MedTech #MedDev #MedicalDevices #IVD https://hubs.li/Q02xjs240

Want to learn how to standardize variant interpretation? Join Labroots at the 2024 Precision Medicine Virtual Event for the panel presentation titled, “Mitigating Variability in Somatic Variant Interpretation with Live Q&A” on May 15 at 10:30 AM PDT. In this live panel discussion, experts in NGS testing and clinical informatics will explore the issues surrounding the standardization of variant interpretation and consider how interpretation guidelines and clinical decision support (CDS) software can help to mitigate variability between laboratories. Register now to learn more: https://buff.ly/3TYPbjU #LRprecisionmed

Join us for a live webinar on April 24th, The Future of Precision Medicine: Leveraging Clinico-Genomic Data for Germline Disorders. We discuss with #precisionmedicine experts Dr. Christopher O'Donnell from Novartis and Dr. Daniel Judge at Medical University of South Carolina on how linked clinico-genomic data can drive #drugdiscovery and development in the age of precision medicine. Learn about life science use cases and how genetic medicines translate to clinical care in germline disorders. Register here: https://bit.ly/4dcO73I

https://lnkd.in/efBP5KAK Great to see our hCD68-GFP transcriptomics studies on PubMed, well done Gareth, Eileen and Ben. Interesting implications for the role of monocytes and macrophages in inflammation and more great chemotaxis experiments!

Mitochondria can hop into different cell types 😯. Here is an informative article on intercellular mitochondria transfer and its future as a therapeutic strategy.